Blue Chip Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,444
Closed -$256K 103
2020
Q1
$256K Buy
1,444
+50
+4% +$9.41K 0.32% 73
2019
Q4
$266K Sell
1,394
-112
-7% -$20.2K 0.25% 85
2019
Q3
$253K Hold
1,506
0.26% 86
2019
Q2
$252K Hold
1,506
0.27% 83
2019
Q1
$220K Buy
+1,506
New +$218K 0.25% 87
2018
Q4
Sell
-1,531
Closed -$292K 101
2018
Q3
$292K Sell
1,531
-350
-19% -$64.3K 0.29% 80
2018
Q2
$314K Sell
1,881
-142
-7% -$22.8K 0.34% 77
2018
Q1
$340K Buy
+2,023
New +$339K 0.35% 67

Other funds holding AGN

Blue Chip Wealth Management's AGN Position: Q2 2020 in Review

Blue Chip Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,444 shares — an estimated $256K sold.

Blue Chip Wealth Management first reported a position in AGN in Q1 2018 and held it in 8 quarters. The position peaked at $340K in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Blue Chip Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Blue Chip Wealth Management sold 1,444 Allergan plc shares in Q2 2020, an estimated $256K.
  • Blue Chip Wealth Management first reported a position in Allergan plc in Q1 2018 and held it in 8 quarters.
  • Blue Chip Wealth Management's Allergan plc position peaked at $340K in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Blue Chip Wealth Management's 13F filing for Q2 2020, filed 13 Aug 2020.